Literature DB >> 17103171

Lupus patients with pulmonary involvement have a pro-inflammatory cytokines profile.

Sana Al-Mutairi1, Adel Al-Awadhi, Raj Raghupathy, Hanaa Al-Khawari, Prio Sada, Adeebah Al-Herz, Parvez Rawoot.   

Abstract

OBJECTIVES: The literature on cytokine response in systemic lupus erythematosus (SLE) is confusing. It is possible that different disease phenotypes have different cytokine profiles. Our aim was to examine the levels of selected pro-inflammatory and anti-inflammatory cytokines in SLE patients with and without pulmonary involvement. METHODS AND
SUBJECTS: Patients with SLE were interviewed and were subjected to the pulmonary function test and high-resolution computed tomography studies. Serum levels of interleukin (IL)-6, IL-8, IL-10, Il-12, interferon (IFN) gamma, and tumor necrosis factor (TNF) alpha were estimated by enzyme-linked immunosorbent assay.
RESULTS: Forty-nine of the 61 SLE patients had pulmonary involvement. Median levels of IL-8, IFNgamma, and TNFalpha were significantly higher in the pulmonary group as compared to the non-pulmonary group (p = 0.027, 0.027 and 0.002, respectively). Ratios of pro-inflammatory cytokines to anti-inflammatory cytokines were higher in the pulmonary group as compared to the non-pulmonary group as well as in the pulmonary restrictive subgroup compared to the obstructive subgroup.
CONCLUSION: Lupus patients with pulmonary involvement have a stronger pro-inflammatory cytokine bias than those without pulmonary involvement.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17103171     DOI: 10.1007/s00296-006-0268-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  46 in total

Review 1.  Cytokines and systemic lupus erythematosus.

Authors:  G S Dean; J Tyrrell-Price; E Crawley; D A Isenberg
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

Review 2.  The roles of interleukin-6 and interleukin-10 in B cell hyperactivity in systemic lupus erythematosus.

Authors:  J T Cross; H P Benton
Journal:  Inflamm Res       Date:  1999-05       Impact factor: 4.575

3.  In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: lack of relationship with clinical disease activity.

Authors:  W Barcellini; G P Rizzardi; M O Borghi; F Nicoletti; C Fain; N Del Papa; P L Meroni
Journal:  Lupus       Date:  1996-04       Impact factor: 2.911

4.  Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus.

Authors:  E M Davas; A Tsirogianni; I Kappou; D Karamitsos; I Economidou; P C Dantis
Journal:  Clin Rheumatol       Date:  1999       Impact factor: 2.980

5.  Association of interleukin 6 release from endothelial cells and pulmonary hypertension in SLE.

Authors:  T Yoshio; J I Masuyama; N Kohda; D Hirata; H Sato; M Iwamoto; A Mimori; A Takeda; S Minota; S Kano
Journal:  J Rheumatol       Date:  1997-03       Impact factor: 4.666

6.  Prevalence of asthma, allergic rhinitis, and eczema in 13- to 14-year-old children in Kuwait: an ISAAC study. International Study of Asthma and Allergies in Childhood.

Authors:  N A Behbehani; A Abal; N C Syabbalo; A Abd Azeem; E Shareef; J Al-Momen
Journal:  Ann Allergy Asthma Immunol       Date:  2000-07       Impact factor: 6.347

7.  Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus.

Authors:  L Llorente; Y Richaud-Patin; C García-Padilla; E Claret; J Jakez-Ocampo; M H Cardiel; J Alcocer-Varela; L Grangeot-Keros; D Alarcón-Segovia; J Wijdenes; P Galanaud; D Emilie
Journal:  Arthritis Rheum       Date:  2000-08

8.  Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus.

Authors:  C K Wong; C Y Ho; E K Li; C W Lam
Journal:  Lupus       Date:  2000       Impact factor: 2.911

9.  Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases.

Authors:  M al-Janadi; S al-Balla; A al-Dalaan; S Raziuddin
Journal:  J Clin Immunol       Date:  1993-01       Impact factor: 8.317

Review 10.  [Cytokines and lupus].

Authors:  D Emilie; L Llorente; P Galanaud
Journal:  Ann Med Interne (Paris)       Date:  1996
View more
  10 in total

1.  Endotoxin tolerance in monocytes can be mitigated by α2-interferon.

Authors:  Lihua Shi; Li Song; Kelly Maurer; James Sharp; Zhe Zhang; Kathleen E Sullivan
Journal:  J Leukoc Biol       Date:  2015-07-23       Impact factor: 4.962

2.  Transplantation of umbilical cord mesenchymal stem cells alleviates pneumonitis of MRL/lpr mice.

Authors:  Yanju Zhang; Yunfei Xia; Songshi Ni; Zhifeng Gu; Hua Liu
Journal:  J Thorac Dis       Date:  2014-02       Impact factor: 2.895

3.  Novel treatments for systemic lupus erythematosus.

Authors:  Wen Xiong; Robert G Lahita
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-10       Impact factor: 5.346

4.  Selected growth factors and diffusing capacity of the lung for carbon monoxide in patients with systemic lupus erythematosus.

Authors:  Antoni Hrycek; Władysław Pierzchała; Anna Osławska-Dzierzega; Paweł Cieślik
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

5.  Superantigen influence in conjunction with cytokine polymorphism potentiates autoimmunity in systemic lupus erythematosus patients.

Authors:  Sajad Ahmad Dar; Essam Mohammed Ahmed Janahi; Shafiul Haque; Naseem Akhter; Arshad Jawed; Mohd Wahid; Vishnampettai Ganapathysubramanian Ramachandran; Sambit Nath Bhattacharya; Basu Dev Banerjee; Shukla Das
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

Review 6.  Therapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN-gamma targeting gene therapy.

Authors:  Toshiharu Hayashi
Journal:  J Biomed Biotechnol       Date:  2010-08-17

7.  Down-regulated NOD2 by immunosuppressants in peripheral blood cells in patients with SLE reduces the muramyl dipeptide-induced IL-10 production.

Authors:  Shui-Lian Yu; Chun-Kwok Wong; Purple Tsz-Yan Wong; Da-Peng Chen; Cheuk-Chun Szeto; Edmund K Li; Lai-Shan Tam
Journal:  PLoS One       Date:  2011-08-19       Impact factor: 3.240

Review 8.  Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE.

Authors:  Ding-Lei Su; Zhi-Min Lu; Min-Ning Shen; Xia Li; Ling-Yun Sun
Journal:  J Biomed Biotechnol       Date:  2012-02-15

9.  CXCL13, CCL4, and sTNFR as circulating inflammatory cytokine markers in primary and SLE-related autoimmune hemolytic anemia.

Authors:  Boting Wu; Weiguang Wang; Yanxia Zhan; Feng Li; Shanhua Zou; Lihua Sun; Yunfeng Cheng
Journal:  J Transl Med       Date:  2015-04-08       Impact factor: 5.531

10.  Exhaled IL-8 in systemic lupus erythematosus with and without pulmonary fibrosis.

Authors:  Agnieszka Nielepkowicz-Goździńska; Wojciech Fendler; Ewa Robak; Lilianna Kulczycka-Siennicka; Paweł Górski; Tadeusz Pietras; Ewa Brzeziańska; Adam Antczak
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-02-04       Impact factor: 4.291

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.